WESTFIELD CAPITAL MANAGEMENT COMPANY, L.P.

Company

Ascendis Pharma A/S

Filed

February 2, 2023

Accession Number

0001085146-23-000558

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →